002019 亿帆医药
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)1.2054.6334.596-6.4502.205
总资产报酬率 ROA (%)0.8323.1993.245-4.5841.548
投入资产回报率 ROIC (%)0.9353.5903.595-5.0541.707

边际利润分析
销售毛利率 (%)45.83146.87947.42047.84048.635
营业利润率 (%)9.5638.3517.400-21.6983.748
息税前利润/营业总收入 (%)11.1539.2728.961-19.9164.665
净利润/营业总收入 (%)7.6237.2766.272-21.7713.312

收益指标分析
经营活动净收益/利润总额(%)112.617103.099103.341-3.012118.914
价值变动净收益/利润总额(%)-3.854-6.479-3.6441.733-11.250
营业外收支净额/利润总额(%)0.658-1.1661.762-1.5748.249

偿债能力分析
流动比率 (X)1.3371.2931.2651.4861.678
速动比率 (X)0.9320.8780.9111.0621.300
资产负债率 (%)31.79632.18431.41028.21627.083
带息债务/全部投入资本 (%)20.39220.33320.35118.59319.214
股东权益/带息债务 (%)380.361381.373380.457425.239404.494
股东权益/负债合计 (%)217.801213.703220.831255.052259.376
利息保障倍数 (X)7.3089.1176.274-13.7728.048

营运能力分析
应收账款周转天数 (天)101.02596.84686.279101.414105.968
存货周转天数 (天)160.785152.734131.654149.262136.536